New immune checkpoints such as HLA-G and its receptors emerge as targets for cancer treatment (Amiot et al, 2011; Carosella et al, 2015; Barkal et al, 2018; Krijgsman et al, 2020). This evidence concerns the gene HLA-G and cancer.